首页期刊导航|世界胃肠病学杂志(英文版)
期刊信息/Journal information
世界胃肠病学杂志(英文版)
世界胃肠病学杂志(英文版)

潘伯荣

周刊

1007-9327

wjg@wjgnet.com

010-85381901-628

100025

北京市朝阳区东四环中路62号楼远洋国际中心D座903室

世界胃肠病学杂志(英文版)/Journal World Journal of GastroenterologyCSCDCSTPCDSCI
查看更多>>主要报道和刊登国内外、特别是我国消化病学者具有创造性的、有较高学术水平的基础和临床研究论文、研究快报等. 对具有中国特色的研究论文, 如食管癌、胃癌、肝癌、大肠癌、病毒性肝炎、幽门螺杆菌、中医中药、中西医结合和基于作者自己研究工作为主的综述性论文, 将优先发表. 读者对象为基础研究或临床研究的消化专业工作者。
正式出版
收录年代

    Update on risk scoring systems for patients with upper gastrointestinal haemorrhage

    Adrian J Stanley
    2739-2744页
    查看更多>>摘要:Upper gastrointestinal haemorrhage (UGIH) remains a common medical emergency worldwide.It is increasingly recognised that early risk assessment is an important part of management,which helps direct appropriate patient care and the timing of endoscopy.Several risk scores have been developed,most of which include endoscopic findings,although a minority do not.These scores were developed to identify various end-points including mortality,rebleeding or clinical intervention in the form of transfusion,endoscopic therapy or surgery.Recent studies have reported accurate identification of a very low risk group on presentation,using scores which require simple clinical or laboratory parameters only.This group may not require admission,but could be managed with early out-patient endoscopy.This article aims to describe the existing pre- and post-en-doscopy risk scores for UGIH and assess the published data comparing them in the prediction of outcome.Recent data assessing their use in clinical practice,in particular the early identification of low-risk patients,are also discussed.

    Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer

    Hiroyuki YamamotoYasushi AdachiHiroaki TaniguchiHiroaki Kunimoto...
    2745-2755页
    查看更多>>摘要:There is an increasing understanding of the roles that microsatellite instability (MSI) plays in Lynch syndrome (by mutations) and sporadic (by mainly epigenetic changes) gastrointestinal (GI) and other cancers.Deficient DNA mismatch repair (MMR) results in the strong mutator phenotype known as MSI,which is the hallmark of cancers arising within Lynch syndrome.MSI is characterized by length alterations within simple repeated sequences called microsatellites.Lynch syndrome occurs primarily because of germline mutations in one of the MMR genes,mainly MLH1 or MSH2,less frequently MSH6,and rarely PMS2.MSI is also observed in about 15% of sporadic colorectal,gastric,and endometrial cancers and in lower frequencies in a minority of other cancers where it is often associated with the hypermethylation of the MLH1 gene.miRNAs are small noncoding RNAs that regulate gene expression at the posttranscriptional level and are critical in many biological processes and cellular pathways.There is accumulating evidence to support the notion that theinterrelationship between MSI and miRNA plays a key role in the pathogenesis of GI cancer.As a possible new mechanism underlying MSI,overexpression of miR-155 has been shown to downregulate expression of MLH1,MSH2,and MSH6.Thus,a subset of MSI-positive (MSI+)cancers without known MMR defects may result from miR-155 overexpression.Target genes of frameshift mutation for MSI are involved in various cellular functions,such as DNA repair,cell signaling,and apoptosis.A novel class of target genes that included not only epigenetic modifier genes,such as HDAC2,but also miRNA processing machinery genes,including TARBP2 and XPO5,were found to be mutated in MSI+ GI cancers.Thus,a subset of MSI+ colorectal cancers (CRCs) has been proposed to exhibit a mutated miRNA machinery phenotype.Genetic,epigenetic,and transcriptomic differences exist between MSI+ and MSI-cancers.Molecular signatures of miRNA expression apparently have the potential to distinguish between MSI+ and MSICRCs.In this review,we summarize recent advances in the MSI pathogenesis of GI cancer,with the focus on its relationship with miRNA as well as on the potential to use MSI and related alterations as biomarkers and novel therapeutic targets.

    Toxic hepatitis in occupational exposure to solvents

    Giulia MalaguarneraEmanuela CataudellaMaria GiordanoGiuseppe Nunnari...
    2756-2766页
    查看更多>>摘要:The liver is the main organ responsible for the metabolism of drugs and toxic chemicals,and so is the primary target organ for many organic solvents.Work activities with hepatotoxins exposures are numerous and,moreover,organic solvents are used in various industrial processes.Organic solvents used in different industrial processes may be associated with hepatotoxicity.Several factors contribute to liver toxicity; among these are:species differences,nutritional condition,genetic factors,interaction with medications in use,alcohol abuse and interaction,and age.This review addresses the mechanisms of hepatotoxicity.The main pathogenic mechanisms responsible for functional and organic damage caused by solvents are:inflammation,dysfunction of cytochrome P450,mitochondrial dysfunction and oxidative stress.The health impact of exposure to solvents in the workplace remains an interesting and worrying question for professional health work.

    Simple and reproducible hepatectomy in the mouse using the clip technique

    Tomohide HoriNorifumi OhashiFeng ChenAnn-Marie T Baine...
    2767-2774页
    查看更多>>摘要:AIM:TO investigate the reliability of massive hepatectomy models by using clip techniques.METHODS:We analyzed anatomical findings in 100 mice following massive hepatectomy induced by liver reduction > 70%.The impact of various factors in the different models was also analyzed,including learning curves,operative time,survival curves,and histopathological findings.RESULTS:According to anatomical results,models with 75%,80%,and 90% hepatectomy produced massive hepatectomy.Learning curves and operative times were most optimal with the clip technique.Each hepatectomy performed using the clip technique produced a reasonable survival curve,and there were no differences in histopathological findings between the suture and clip techniques.CONCLUSION:Massive hepatectomy by the clip technique is simple and can provide reliable and relevant data.

    Regional lymphadenectomy for gallbladder cancer: Rational extent, technical details, and patient outcomes

    Yoshio ShiraiToshifumi WakaiJun SakataKatsuyoshi Hatakeyama...
    2775-2783页
    查看更多>>摘要:AIM:To define the rational extent of regional lymphadenectomy for gallbladder cancer and to clarify its effect on long-term survival.METHODS:A total of 152 patients with gallbladder cancer who underwent a minimum of "extended" portal lymph node dissection (defined as en bloc removal of the first- and second-echelon nodes) from 1982 to 2010 were retrospectively analyzed.Based on previous studies,regional lymph nodes of the gallbladder were divided into first-echelon nodes (cystic duct or pericholedochal nodes),second-echelon nodes (node groups posterosuperior to the head of the pancreas or around the hepatic vessels),and more distant nodes.RESULTS:Among the 152 patients (total of 3352 lymph nodes retrieved,median of 19 per patient),79 patients (52%) had 356 positive nodes.Among nodepositive patients,the prevalence of nodal metastasis was highest in the pericholedochal (54%) and cystic duct (38%) nodes,followed by the second-echelon node groups (29% to 19%),while more distant node groups were only rarely (5% or less) involved.Diseasespecific survival after R0 resection differed according to the nodal status (P < 0.001):most node-negative patients achieved long-term survival (median,not reached; 5-year survival,80%),whereas among nodepositive patients,22 survived for more than 5 years (median,37 mo; 5-year survival,43%).CONCLUSION:The rational extent of lymphadenectomy for gallbladder cancer should include the firstand second-echelon nodes.A considerable proportion of node-positive patients benefit from such aggressive lymphadenectomy.

    Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients

    Xu-Dong LiuJian-Lin WuJian LiangTao Zhang,...
    2784-2792页
    查看更多>>摘要:AIM:To establish a simple model consisting of the routine laboratory variables to predict both minimal fibrosis and cirrhosis in chronic hepatitis B virus (HBV)-infected patients.METHODS:We retrospectively investigated 114 chronic HBV-infected patients who underwent liver biopsy in two different hospitals.Thirteen parameters were analyzed by step-wise regression analysis and correlation analysis.A new fibrosis index [globulin/platelet (GP) model] was developed,including globulin (GLOB) and platelet count (PLT).GP model =GLOB (g/mL) x 100/PLT (x 109/L).We evaluated the receiver operating characteristics analysis used to predict minimal fibrosis and compared six other available models.RESULTS:Thirteen clinical biochemical and hematological variables [sex,age,PLT,alanine aminotransferase,aspartate aminotransferase (AST),albumin,GLOB,total bilirubin (T.bil),direct bilirubin (D.bil),glutamyl transferase,alkaline phosphatase,HBV DNA and prothrombin time (PT)] were analyzed according to three stages of liver fibrosis (F0-F1,F2-F3 and F4).Bivariate Spearman's rank correlation analysis showed that six variables,including age,PLT,T.bil,D.bil,GLOB and PT,were correlated with the three fibrosis stages (FS).Correlation coefficients were 0.23,-0.412,0.208,0.220,0.314 and 0.212; and P value was 0.014,< 0.001,0.026,0.018,0.001 and 0.024,respectively.Univariate analysis revealed that only PLT and GLOB were significantly different in the three FS (PLT:F =11.772,P <0.001; GLOB:F =6.612,P =0.002).Step-wise multiple regression analysis showed that PLT and GLOB were also independently correlated with FS (R2 =0.237).By Spearman's rank correlation analysis,GP model was significantly correlated with the three FS (r =0.466,P < 0.001).The median values in F0-F1,F2-F3 and F4 were 1.461,1.720 and 2.634.Compared with the six available models (fibrosis index,AST-platelet ratio,FIB-4,fibrosis-cirrhosis index and age-AST model and age-PLT ratio),GP model showed a highest correlation coefficient.The sensitivity and positive predictive value at a cutoff value < 1.68 for predicting minimal fibrosis F0-F1 were 72.4% and 71.2%,respectively.The specificity and negative predictive value at a cutoff value < 2.53 for the prediction of cirrhosis were 84.5% and 96.7%.The area under the curve (AUC) of GP model for predicting minimal fibrosis and cirrhosis was 0.762 [95% confidence interval (CI):0.676-0.848] and 0.781 (95% CI:0.638-0.924).Although the differences were not statistically significant between GP model and the other models (P all > 0.05),the AUC of GP model was the largest among the seven models.CONCLUSION:By establishing a simple model using available laboratory variables,chronic HBV-infected patients with minimal fibrosis and cirrhosis can be diagnosed accurately,and the clinical application of this model may reduce the need for liver biopsy in HBVinfected patients.

    Transepithelial leak in Barrett's esophagus patients: The role of proton pump inhibitors

    Christopher FarrellMelissa MorganOwen TullyKevin Wolov...
    2793-2797页
    查看更多>>摘要:AIM:To determine if the observed paracellular sucrose leak in Barrett's esophagus patients is due to their proton pump inhibitor (PPI) use.METHODS:The in vivo sucrose permeability test was administered to healthy controls,to Barrett's patients and to non-Barrett's patients on continuous PPI therapy.Degree of leak was tested for correlation with presence of Barrett's,use of PPIs,and length of Barrett's segment and duration of PPI use.RESULTS:Barrett's patients manifested a near 3-fold greater,upper gastrointestinal sucrose leak than healthy controls.A decrease of sucrose leak was observed in Barrett's patients who ceased PPI use for 7 d.Although initial introduction of PPI use (in a PPI-nafve population) results in dramatic increase in sucrose leak,long-term,continuous PPI use manifested a slow spontaneous decline in leak.The sucrose leak observed in Barrett's patients showed no correlation to the amount of Barrett's tissue present in the esophagus.CONCLUSION:Although future research is needed to determine the degree of paracellular leak in actual Barrett's mucosa,the relatively high degree of leak observed with in vivo sucrose permeability measurement of Barrett's patients reflects their PPI use and not their Barrett's tissue per se.

    Plasma microRNA profiles distinguish lethal injury in acetaminophen toxicity: A research study

    Jeanine WardShashi BalaJan PetrasekGyongyi Szabo...
    2798-2804页
    查看更多>>摘要:AIM:To investigate plasma microRNA (miRNA) profiles indicative of hepatotoxicity in the setting of lethal acetaminophen (APAP) toxicity in mice.METHODS:Using plasma from APAP poisoned mice,either lethally (500 mg/kg) or sublethally (150 mg/kg) dosed,we screened commercially available murine microRNA libraries (SABiosciences,Qiagen Sciences,MD) to evaluate for unique miRNA profiles between these two dosing parameters.RESULTS:We distinguished numerous,unique plasma miRNAs both up- and downregulated in lethally compared to sublethally dosed mice.Of note,many of the greatest up- and downregulated miRNAs,namely 574-5p,466g,466f-3p,375,29c,and 148a,have been shown to be associated with asthma in prior studies.Interestingly,a relationship between APAP and asthma has been previously well described in the literature,with an as yet unknown mechanism of pathology.There was a statistically significant increase in alanine aminotransferase levels in the lethal compared to sublethal APAP dosing groups at the 12 h time point (P <0.001).There was 90% mortality in the lethally compared to sublethally dosed mice at the 48 h time point (P =0.011).CONCLUSION:We identified unique plasma miRNAs both up- and downregulated in APAP poisoning which are correlated to asthma development.

    Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk

    Mathilde TouvierLéopold FezeuNamanjeet AhluwaliaChantal Julia...
    2805-2812页
    查看更多>>摘要:AIM:To examine the relationships between pre-diag-nostic biomarkers and colorectal cancer risk and assess their relevance in predictive models.METHODS:A nested case-control study was designed to include all first primary incident colorectal cancer cases diagnosed between inclusion in the SUpplementation en VItamines et Minéraux AntioXydants cohort in 1994 and the end of follow-up in 2007.Cases (n =50) were matched with two randomly selected controis (n =100).Conditional logistic regression models were used to investigate the associations between prediagnostic levels of hs-CRP,adiponectin,leptin,soluble vascular cell adhesion molecule-1 (sVCAM-1),soluble intercellular adhesion molecule-1,E-selectin,monocyte chemoattractant protein-1 and colorectal cancer risk.Area under the receiver operating curves (AUC) and relative integrated discrimination improvement (RIDI) statistics were used to assess the discriminatory poten tial of the models.RESULTS:Plasma adiponectin level was associated with decreased colorectal cancer risk (P for linear trend =0.03).Quartiles of sVCAM-1 were associated with increased colorectal cancer risk (P for linear trend =0.02).No association was observed with any of the other biomarkers.Compared to standard models with known risk factors,those including both adiponectin and sVCAM-1 had substantially improved performance for colorectal cancer risk prediction (P for AUC improvement =0.01,RIDI =26.5%).CONCLUSION:These results suggest that pre-diagnostic plasma adiponectin and sVCAM-1 levels are associated with decreased and increased colorectal cancer risk,respectively.These relationships must be confirmed in large validation studies.

    Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis

    Luca ValentiPaolo MaggioniAlberto PipernoRaffaela Rametta...
    2813-2820页
    查看更多>>摘要:AIM:To investigate whether the patatin-/ike phospho/ipase domain containing-3 gene (PNPLA3) I148M polymorphism is associated with steatosis,fibrosis stage,and cirrhosis in hereditary hemochromatosis (HH).METHODS:We studied 174 consecutive unrelated homozygous for the C282Y HFE mutation of HH (C282Y+/+ HH) patients from Northern Italy,for whom the presence of cirrhosis could be determined based on histological or clinical criteria,without excessive alcohol intake (< 30/20 g/d in males or females) or hepatitis B virus and hepatitis C virus viral hepatitis.Steatosis was evaluated in 123 patients by histology (n =100) or ultrasound (n =23).The PNPLA3 rs738409 single nucleotide polymorphism,encoding for the p.148M protein variant,was genotyped by a Taqman assay (assay on demand,Applied Biosystems).The association of the PNPLA3 I148M protein variant (p.I148M) with steatosis,fibrosis stage,and cirrhosis was evaluated by logistic regression analysis.RESULTS:PNPLA3 genotype was not associated with metabolic parameters,including body mass index (BMI),the presence of diabetes,and lipid levels,but the presence of the p.148M variant at risk was independently associated with steatosis [odds ratio (OR) 1.84 per p.148M allele,95% confidence interval (CI):1.05-3.31;P =0.037],independently of BMI and alanine aminotransaminase (ALT) levels.The p.148M variant was also associated with higher aspartate aminotransferase (P =0.0014) and ALT levels (P =0.017) at diagnosis,independently of BMI and the severity of iron overload.In patients with liver biopsy,the 148M variant was independently associated with the severity (stage) of fibrosis (estimated coefficient 0.56 ± 0.27,P =0.041).In the overall series of patients,the p.148M variant was associated with cirrhosis in lean (P =0.049),but not in overweight patients (P =not significant).At logistic regression analysis,cirrhosis was associated with BMI ≥ 25 (OR 1.82,95% CI:1.02-3.55),ferritin > 1000 ng/mL at diagnosis (OR 19.3,95% CI:5.3-125),and with the G allele in patients with BMI < 25 (OR 3.26,95% CI:1.3-10.3).CONCLUSION:The PNPLA3 I148M polymorphism may represent a permissive factor for fibrosis progression in patients with C282Y+/+ HH.